Behandling med CEPROTIN bør påbegyndes under overvågning af en læge med erfaring i substitutionsterapi med koagulationsfaktorer/ inhibitorer, hvor overvågning af protein C aktivitet er mulig.
Treatment with CEPROTIN should be initiated under the supervision of a physician experienced in substitution therapy with coagulation factors/ inhibitors where monitoring of protein C activity is feasible.